{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:39:52Z","timestamp":1770410392849,"version":"3.49.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1093\/intimm\/dxh238","type":"journal-article","created":{"date-parts":[[2005,5,21]],"date-time":"2005-05-21T00:14:28Z","timestamp":1116634468000},"page":"677-684","source":"Crossref","is-referenced-by-count":13,"title":["Aberrant gene expression by CD25+CD4+ immunoregulatory T cells in autoimmune-prone rats carrying the human T cell leukemia virus type-I gene"],"prefix":"10.1093","volume":"17","author":[{"given":"Hiroko","family":"Hayase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utano","family":"Tomaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yoshiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,5,20]]},"reference":[{"key":"key\n\t\t\t\t20171012164838_BIB1","doi-asserted-by":"crossref","unstructured":"Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D. and Gallo, R. C. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl Acad. Sci. USA77:7415.","DOI":"10.1073\/pnas.77.12.7415"},{"key":"key\n\t\t\t\t20171012164838_BIB2","doi-asserted-by":"crossref","unstructured":"Yoshida, M., Miyoshi, I. and Hinuma, Y. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl Acad. Sci. USA79:2031.","DOI":"10.1073\/pnas.79.6.2031"},{"key":"key\n\t\t\t\t20171012164838_BIB3","doi-asserted-by":"crossref","unstructured":"Gessain, A., Barin, F., Vernant, J. C. et al.1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet2:407.","DOI":"10.1016\/S0140-6736(85)92734-5"},{"key":"key\n\t\t\t\t20171012164838_BIB4","unstructured":"Osame, M., Usuku, K., Izumo, S. et al.1986. HTLV-I associated myelopathy, a new clinical entity. Lancet1:1031."},{"key":"key\n\t\t\t\t20171012164838_BIB5","doi-asserted-by":"crossref","unstructured":"Mochizuki, M., Watanabe, T., Yamaguchi, K. et al.1992. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn. J. Cancer Res.83:236.","DOI":"10.1111\/j.1349-7006.1992.tb00092.x"},{"key":"key\n\t\t\t\t20171012164838_BIB6","doi-asserted-by":"crossref","unstructured":"Nishioka, K., Maruyama, I., Sato, K., Kitajima, I., Nakajima, Y. and Osame, M. 1989. Chronic inflammatory arthropathy associated with HTLV-I. Lancet1:441.","DOI":"10.1016\/S0140-6736(89)90038-X"},{"key":"key\n\t\t\t\t20171012164838_BIB7","unstructured":"Vernant, J. C., Buisson, G., Magdeleine, J. et al.1988. T lymphocyte alveolitis, tropical spastic paraparesis, and Sj\u00f6gren's syndrome. Lancet1:177."},{"key":"key\n\t\t\t\t20171012164838_BIB8","doi-asserted-by":"crossref","unstructured":"Sugimoto, M., Nakashima, H., Watanabe, S. et al.1987. T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet2:1220.","DOI":"10.1016\/S0140-6736(87)91362-6"},{"key":"key\n\t\t\t\t20171012164838_BIB9","doi-asserted-by":"crossref","unstructured":"LaGrenade, L., Hanchard, B., Fletcher, V., Cranston, B. and Blattner, W. 1990. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet336:1345.","DOI":"10.1016\/0140-6736(90)92896-P"},{"key":"key\n\t\t\t\t20171012164838_BIB10","doi-asserted-by":"crossref","unstructured":"Yamazaki, H., Ikeda, H., Ishizu, A. et al.1997. A wide spectrum of collagen vascular and autoimmune diseases in transgenic rats carrying the env-pX gene of human T lymphocyte virus type I. Int. Immunol.9:339.","DOI":"10.1093\/intimm\/9.2.339"},{"key":"key\n\t\t\t\t20171012164838_BIB11","doi-asserted-by":"crossref","unstructured":"Yamazaki, H., Kunisada, T., Ishizu, A. et al.1998. Promotion of early osteogenesis and B lymphopoiesis in the bone marrow of transgenic rats with the env-pX gene of human T-cell lymphotropic virus type I. Oncogene17:2955.","DOI":"10.1038\/sj.onc.1202222"},{"key":"key\n\t\t\t\t20171012164838_BIB12","doi-asserted-by":"crossref","unstructured":"Nakamaru, Y., Ishizu, A., Ikeda, H. et al.2001. Immunological hyper-responsiveness in HTLV-I LTR-env-pX transgenic rats: a prototype animal model for collagen vascular and HTLV-I-related inflammatory diseases. Pathobiology69:11.","DOI":"10.1159\/000048752"},{"key":"key\n\t\t\t\t20171012164838_BIB13","doi-asserted-by":"crossref","unstructured":"Fugo, K., Ishizu, A., Ikeda, H. et al.2002. The role of the thymus in development of necrotizing arteritis in transgenic rats carrying the env-pX gene of human T-cell leukemia virus type-I. Am. J. Pathol.161:755.","DOI":"10.1016\/S0002-9440(10)64234-4"},{"key":"key\n\t\t\t\t20171012164838_BIB14","doi-asserted-by":"crossref","unstructured":"Higuchi, M., Ishizu, A., Ikeda, H. et al.2003. Functional alteration of peripheral CD25+CD4+ immunoregulatory T cells in a transgenic rat model of autoimmune diseases. J. Autoimmun.20:43.","DOI":"10.1016\/S0896-8411(02)00090-2"},{"key":"key\n\t\t\t\t20171012164838_BIB15","doi-asserted-by":"crossref","unstructured":"Itoh, M., Takahashi, T., Sakaguchi, N. et al.1999. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol.162:5317.","DOI":"10.4049\/jimmunol.162.9.5317"},{"key":"key\n\t\t\t\t20171012164838_BIB16","doi-asserted-by":"crossref","unstructured":"Jordan, M. S., Boesteanu, A., Reed, A. J. et al.2001. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol.2:301.","DOI":"10.1038\/86302"},{"key":"key\n\t\t\t\t20171012164838_BIB17","doi-asserted-by":"crossref","unstructured":"Miyatake, Y., Ikeda, H., Michimata, R. et al.2004. Differential modulation of gene expression among rat tissues with warm ischemia. Exp. Mol. Pathol.77:222.","DOI":"10.1016\/j.yexmp.2004.07.004"},{"key":"key\n\t\t\t\t20171012164838_BIB18","doi-asserted-by":"crossref","unstructured":"Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science299:1057.","DOI":"10.1126\/science.1079490"},{"key":"key\n\t\t\t\t20171012164838_BIB19","doi-asserted-by":"crossref","unstructured":"Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol.4:330.","DOI":"10.1038\/ni904"},{"key":"key\n\t\t\t\t20171012164838_BIB20","doi-asserted-by":"crossref","unstructured":"Kampinga, J., Groen, H., Klatter, F. et al.1992. Post-thymic T cell development in rats: an update. Biochem. Soc. Trans.20:191.","DOI":"10.1042\/bst0200191"},{"key":"key\n\t\t\t\t20171012164838_BIB21","doi-asserted-by":"crossref","unstructured":"Sarawar, S. R., Sparshott, S. M., Sutton, P., Yang, C. P., Hutchinson, I. V. and Bell, E. B. 1993. Rapid re-expression of CD45RC on rat CD4 T cells in vitro correlates with a change in function. Eur. J. Immunol.23:103.","DOI":"10.1002\/eji.1830230117"},{"key":"key\n\t\t\t\t20171012164838_BIB22","unstructured":"Waldmann, T. A. 1986. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science232:727."},{"key":"key\n\t\t\t\t20171012164838_BIB23","doi-asserted-by":"crossref","unstructured":"Kodaka, T., Uchiyama, T., Ishikawa, T. et al.1990. Interleukin-2 receptor beta-chain (p70\u201375) expressed on leukemic cells from adult T cell leukemia patients. Jpn. J. Cancer Res.81:902.","DOI":"10.1111\/j.1349-7006.1990.tb02665.x"},{"key":"key\n\t\t\t\t20171012164838_BIB24","doi-asserted-by":"crossref","unstructured":"Starr, R., Willson, T. A., Viney, E. M. et al.1997. A family of cytokine-inducible inhibitors of signalling. Nature387:917.","DOI":"10.1038\/43206"},{"key":"key\n\t\t\t\t20171012164838_BIB25","doi-asserted-by":"crossref","unstructured":"Alexander, W. S. and Hilton, D. J. 2004. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol.22:503.","DOI":"10.1146\/annurev.immunol.22.091003.090312"},{"key":"key\n\t\t\t\t20171012164838_BIB26","doi-asserted-by":"crossref","unstructured":"Sakaguchi, S. 2004. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune reponses. Annu. Rev. Immunol.22:531.","DOI":"10.1146\/annurev.immunol.21.120601.141122"},{"key":"key\n\t\t\t\t20171012164838_BIB27","doi-asserted-by":"crossref","unstructured":"Sakaguchi, S., Fukuma, K., Kuribayashi, K. and Masuda, T. 1985. Organ specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self tolerance; deficit of a T cell subset as a possible cause of autoimmune diseases. J. Exp. Med.161:72.","DOI":"10.1084\/jem.161.1.72"},{"key":"key\n\t\t\t\t20171012164838_BIB28","doi-asserted-by":"crossref","unstructured":"Sugihara, S., Izumi, Y., Yoshioka, T. et al.1988. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis. J. Immunol.14:105.","DOI":"10.4049\/jimmunol.141.1.105"},{"key":"key\n\t\t\t\t20171012164838_BIB29","doi-asserted-by":"crossref","unstructured":"Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol.155:1151.","DOI":"10.4049\/jimmunol.155.3.1151"},{"key":"key\n\t\t\t\t20171012164838_BIB30","doi-asserted-by":"crossref","unstructured":"Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A. et al.2001. Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet.27:68.","DOI":"10.1038\/83784"},{"key":"key\n\t\t\t\t20171012164838_BIB31","doi-asserted-by":"crossref","unstructured":"Wu, A. J., Hua, H., Munson, S. H. and McDevitt, H. O. 2002. Tumor necrosis factor-\u03b1 regulation of CD4+CD25+ T cell levels in NOD mice. Proc. Natl Acad. Sci. USA99:12287.","DOI":"10.1073\/pnas.172382999"},{"key":"key\n\t\t\t\t20171012164838_BIB32","doi-asserted-by":"crossref","unstructured":"Sakaguchi, S. 2003. The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery. J. Clin. Investig.112:1310.","DOI":"10.1172\/JCI200320274"},{"key":"key\n\t\t\t\t20171012164838_BIB33","doi-asserted-by":"crossref","unstructured":"Rane, S. G. and Reddy, E. P. 2000. Janus kinases: components of multiple signaling pathways. Oncogene19:5662.","DOI":"10.1038\/sj.onc.1203925"},{"key":"key\n\t\t\t\t20171012164838_BIB34","doi-asserted-by":"crossref","unstructured":"Bromberg, J. F. 2001. Activation of STAT proteins and growth control. Bioessays23:161.","DOI":"10.1002\/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0"},{"key":"key\n\t\t\t\t20171012164838_BIB35","doi-asserted-by":"crossref","unstructured":"Schindler, C. 1999. Cytokines and JAK-STAT signaling. Exp. Cell Res.253:7.","DOI":"10.1006\/excr.1999.4670"},{"key":"key\n\t\t\t\t20171012164838_BIB36","unstructured":"Ivashkiv, L. B. 2000. Jak-STAT signaling pathways in cells of the immune system. Rev. Immunogenet.2:220."},{"key":"key\n\t\t\t\t20171012164838_BIB37","doi-asserted-by":"crossref","unstructured":"McHugh, R. S., Whitters, M. J., Piccirillo, C. A. et al.2002. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity16:311.","DOI":"10.1016\/S1074-7613(02)00280-7"},{"key":"key\n\t\t\t\t20171012164838_BIB38","doi-asserted-by":"crossref","unstructured":"Migone, T. S., Lin, J. X., Cereseto, A. et al.1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science269:79.","DOI":"10.1126\/science.7604283"},{"key":"key\n\t\t\t\t20171012164838_BIB39","doi-asserted-by":"crossref","unstructured":"Xu, X., Kang, S. H., Heidenreich, O., Okerholm, M., O'Shea, J. J. and Nerenberg, M. I. 1995. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) Tax protein or virus-transformed cells. J. Clin. Investig.96:1548.","DOI":"10.1172\/JCI118193"},{"key":"key\n\t\t\t\t20171012164838_BIB40","doi-asserted-by":"crossref","unstructured":"Yu, C. R., Mahdi, R. M., Ebong, S. et al.2004. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling. J. Immunol.173:737.","DOI":"10.4049\/jimmunol.173.2.737"},{"key":"key\n\t\t\t\t20171012164838_BIB41","unstructured":"Gatza, M. L., Watt, J. C. and Marriott, S. J. 2003. Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades. Oncogene22:5141."},{"key":"key\n\t\t\t\t20171012164838_BIB42","doi-asserted-by":"crossref","unstructured":"Bennett, C. L., Christie, J., Ramsdell, F. et al.2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet.27:20.","DOI":"10.1038\/83713"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/intimm\/article-pdf\/17\/6\/677\/1952804\/dxh238.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T07:37:50Z","timestamp":1683099470000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/intimm\/article\/17\/6\/677\/671212\/Aberrant-gene-expression-by-CD25CD4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,20]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,5,20]]},"published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxh238","relation":{},"ISSN":["1460-2377","0953-8178"],"issn-type":[{"value":"1460-2377","type":"electronic"},{"value":"0953-8178","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,6]]},"published":{"date-parts":[[2005,5,20]]}}}